Clearbridge Health Ltd. (5C6) Stock Price & Analysis
5C6 Stock Chart & Stats
- Day’s Range
- EUR 0.01 - EUR 0.01
- 52-Week Range
- EUR 0.01 - EUR 0.03
- Previous Close
- EUR 0.01
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 4.50M
- Enterprise Value
- EUR 5.52M
- Total Cash (Recent Filing)
- EUR 4.12M
- Total Debt (Recent Filing)
- EUR 703.00K
- Price to Earnings (P/E)
- ―
- Beta
- -0.72
- Next Earnings
- Aug 18, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Diversified Service Revenue Streams
Clearbridge operates multiple complementary revenue lines—individual screening packages, per-test diagnostics, and employer wellness contracts. This diversified service mix supports recurring contract revenue, cross-sell of follow-up services, and resilience to demand swings across segments over the medium term.
Strong Revenue Rebound In 2025
A 33.9% top-line rebound demonstrates the company can restore demand and scale utilization of clinic and lab capacity. If sustained, higher volumes can improve fixed-cost absorption and provide a path toward operating leverage, making future margin recovery more attainable.
Manageable Reported Leverage
Reported debt levels are modest relative to equity, implying lower immediate refinancing stress and more financial flexibility. This manageable leverage gives the company room to fund operations or targeted investments without acute solvency risk, assuming cash burn can be contained.
Bears Say
Structural Unprofitability
The company has reported multi-year net losses with a material widening in 2025, indicating costs materially exceed gross profit. Persistent operating losses undermine retained earnings and make it harder to achieve sustainable profitability without significant cost restructuring or revenue scale-up.
Consistent Negative Operating And Free Cash Flow
Repeated negative operating and free cash flow signal ongoing cash burn that increases reliance on external financing. Over months, this constrains investment, heightens refinancing and dilution risk, and limits the company’s ability to self-fund growth or shore up operations if losses persist.
Weakened Balance Sheet And Negative ROE
Declining equity and asset bases plus persistent negative returns on equity reflect value erosion and reduced capital buffers. A weakened balance sheet limits strategic flexibility, raises vulnerability to shocks, and makes future capital raises more dilutive or costly for shareholders.
Clearbridge Health Ltd. News
5C6 FAQ
What was Clearbridge Health Ltd.’s price range in the past 12 months?
What is Clearbridge Health Ltd.’s market cap?
When is Clearbridge Health Ltd.’s upcoming earnings report date?
How were Clearbridge Health Ltd.’s earnings last quarter?
Is Clearbridge Health Ltd. overvalued?
Does Clearbridge Health Ltd. pay dividends?
What is Clearbridge Health Ltd.’s EPS estimate?
How many shares outstanding does Clearbridge Health Ltd. have?
What happened to Clearbridge Health Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Clearbridge Health Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Clearbridge Health Ltd.
Established in 2010 and headquartered in Singapore, Clearbridge Health Limited operates as an investment holding company, delivering diverse healthcare solutions globally, including in Singapore, the Philippines, Hong Kong, and Malaysia. The firm's activities are organized into three key divisions: Strategic Investments, Healthcare Systems, and Medical Clinics/Centres. Its extensive range of services encompasses advanced imaging diagnostics, such as general X-ray, CT scans (including dental cone beam), mammography, MRI, and ultrasound. Furthermore, Clearbridge offers general wellness screenings for conditions like diabetes, high blood pressure, and elevated cholesterol, alongside vaccination programs. Specialized care includes renal treatment, clinical services, aesthetic procedures, and dental and orthodontic services. Beyond patient care, the company provides consultancy to healthcare organizations and is involved in the wholesale supply of medicinal and pharmaceutical products.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Ong Choon Yi
- Employees
- 113
- Website
- www.clearbridgehealth.com
- Address
- 37 Jalan Pemimpin, Singapore, CE, 577177, SG
